Carroll Financial Associates’s Lineage Cell Therapeutics LCTX Stock Holding History

Carroll Financial Associates’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-19,431	Closed	-$39K	–	1338
2018 Q3	$39K	Hold	19,431	–	–	﹤0.01%	554
2018 Q2	$35K	Hold	19,431	–	–	﹤0.01%	557
2018 Q1	$45K	Buy	+19,431	New	+$45.6K	﹤0.01%	509
2017 Q4	–	Sell	-19,431	Closed	-$47K	–	1264
2017 Q3	$47K	Hold	19,431	–	–	0.01%	502
2017 Q2	$53K	Hold	19,431	–	–	0.01%	483
2017 Q1	$58K	Hold	19,431	–	–	0.01%	448
2016 Q4	$61K	Hold	19,431	–	–	0.01%	427
2016 Q3	$66K	Hold	19,431	–	–	0.01%	419
2016 Q2	$44K	Hold	19,431	–	–	0.01%	466
2016 Q1	$48K	Sell	19,431 -1,632	-8%	-$3.64K	0.01%	434
2015 Q4	$69K	Hold	21,063	–	–	0.01%	348
2015 Q3	$63K	Hold	21,063	–	–	0.01%	352
2015 Q2	$62K	Buy	+21,063	New	+$81.7K	0.01%	336

Other funds holding LCTX

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IndexIQ Advisors New York $2.82B AUM 12.48% 1-Year Est. Return